Medical Xpress·5 min read·hard
Single-cell platform tracks antibody drug delivery inside stubborn solid tumors
✦AI Summary
Researchers have developed a new platform called single-cell spatial pharmacobiology (SSP) to track how antibody drugs interact with solid tumors. The study reveals that dense tissue surrounding tumors often prevents drugs from reaching their targets.
Why it matters
Understanding why cancer drugs fail at the cellular level is critical for improving treatment efficacy and developing more targeted therapies.
edited by Stephanie Baum , reviewed by Robert Egan
sciencehealth
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 90%
Scientific reporting based on peer-reviewed research.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in